For research use only. Not for therapeutic Use.
Eph Inhibitor 1（Cat No.:I041325）is a small molecule compound that targets Eph receptors, a family of receptor tyrosine kinases involved in various cellular processes, including cell signaling, migration, and adhesion. These receptors play a critical role in the development of several diseases, including cancer and neurological disorders. Eph Inhibitor 1 works by inhibiting the activity of Eph receptors, potentially blocking their contribution to disease progression. Research into Eph Inhibitor 1 focuses on its therapeutic potential in cancer treatment, as well as its ability to modulate cellular pathways involved in tissue repair and regeneration.
| CAS Number | 861249-77-6 |
| Synonyms | 3-(7-amino-3-pyridin-3-ylpyrazolo[1,5-a]pyrimidin-6-yl)phenol |
| Molecular Formula | C17H13N5O |
| Purity | ≥95% |
| IUPAC Name | 3-(7-amino-3-pyridin-3-ylpyrazolo[1,5-a]pyrimidin-6-yl)phenol |
| InChI | InChI=1S/C17H13N5O/c18-16-14(11-3-1-5-13(23)7-11)9-20-17-15(10-21-22(16)17)12-4-2-6-19-8-12/h1-10,23H,18H2 |
| InChIKey | RDCISORSAAOABP-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC(=C1)O)C2=C(N3C(=C(C=N3)C4=CN=CC=C4)N=C2)N |
